Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice

Pier Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, Carla De Giovanni, Ilaria Rossi, Emma Di Carlo, Piero Musiani, William J. Muller, Patrizia Nanni

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Transgenic mice carrying the HER-2/neu proto-oncogene under tissue- specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells present the appropriate major histocompatibility complex (MHC) class I glycoproteins. The purpose of this work was to assess whether mammary carcinomas arising in Tg-MMTVneu mice correctly expressed MHC (H2(q)) class I gene products. We analyzed by flow cytometry 51 primary tumors from 19 transgenic mice. About one-half of the tumors showed a reduced expression of class I antigens. All tumors were highly positive for membrane neu. Some mice had multiple mammary carcinomas with widely different MHC expression levels, and most mice had at least one tumor with a low expression. Treatment with γ-interferon of carcinoma cells cultured in vitro induced a strong reexpression of H-2(q) antigens. Our results suggest that the immune response activated in vivo by HER-2/neu-positive tumors can lead to the emergence of escape variants characterized by a down-regulation of MHC class I products.

Original languageEnglish
Pages (from-to)937-941
Number of pages5
JournalInternational Journal of Cancer
Volume77
Issue number6
DOIs
Publication statusPublished - 1998

Fingerprint

Major Histocompatibility Complex
Transgenic Mice
Down-Regulation
Breast Neoplasms
Neoplasms
H-2 Antigens
MHC Class I Genes
Oncogenic Viruses
Histocompatibility Antigens Class I
Proto-Oncogenes
Terminal Repeat Sequences
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Interferons
Cultured Cells
Glycoproteins
Flow Cytometry
Carcinoma
Membranes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice. / Lollini, Pier Luigi; Nicoletti, Giordano; Landuzzi, Lorena; De Giovanni, Carla; Rossi, Ilaria; Di Carlo, Emma; Musiani, Piero; Muller, William J.; Nanni, Patrizia.

In: International Journal of Cancer, Vol. 77, No. 6, 1998, p. 937-941.

Research output: Contribution to journalArticle

Lollini, Pier Luigi ; Nicoletti, Giordano ; Landuzzi, Lorena ; De Giovanni, Carla ; Rossi, Ilaria ; Di Carlo, Emma ; Musiani, Piero ; Muller, William J. ; Nanni, Patrizia. / Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice. In: International Journal of Cancer. 1998 ; Vol. 77, No. 6. pp. 937-941.
@article{0ae726e14a7b47abaaec7afdcbab1bb8,
title = "Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice",
abstract = "Transgenic mice carrying the HER-2/neu proto-oncogene under tissue- specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells present the appropriate major histocompatibility complex (MHC) class I glycoproteins. The purpose of this work was to assess whether mammary carcinomas arising in Tg-MMTVneu mice correctly expressed MHC (H2(q)) class I gene products. We analyzed by flow cytometry 51 primary tumors from 19 transgenic mice. About one-half of the tumors showed a reduced expression of class I antigens. All tumors were highly positive for membrane neu. Some mice had multiple mammary carcinomas with widely different MHC expression levels, and most mice had at least one tumor with a low expression. Treatment with γ-interferon of carcinoma cells cultured in vitro induced a strong reexpression of H-2(q) antigens. Our results suggest that the immune response activated in vivo by HER-2/neu-positive tumors can lead to the emergence of escape variants characterized by a down-regulation of MHC class I products.",
author = "Lollini, {Pier Luigi} and Giordano Nicoletti and Lorena Landuzzi and {De Giovanni}, Carla and Ilaria Rossi and {Di Carlo}, Emma and Piero Musiani and Muller, {William J.} and Patrizia Nanni",
year = "1998",
doi = "10.1002/(SICI)1097-0215(19980911)77:6<937::AID-IJC24>3.0.CO;2-X",
language = "English",
volume = "77",
pages = "937--941",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice

AU - Lollini, Pier Luigi

AU - Nicoletti, Giordano

AU - Landuzzi, Lorena

AU - De Giovanni, Carla

AU - Rossi, Ilaria

AU - Di Carlo, Emma

AU - Musiani, Piero

AU - Muller, William J.

AU - Nanni, Patrizia

PY - 1998

Y1 - 1998

N2 - Transgenic mice carrying the HER-2/neu proto-oncogene under tissue- specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells present the appropriate major histocompatibility complex (MHC) class I glycoproteins. The purpose of this work was to assess whether mammary carcinomas arising in Tg-MMTVneu mice correctly expressed MHC (H2(q)) class I gene products. We analyzed by flow cytometry 51 primary tumors from 19 transgenic mice. About one-half of the tumors showed a reduced expression of class I antigens. All tumors were highly positive for membrane neu. Some mice had multiple mammary carcinomas with widely different MHC expression levels, and most mice had at least one tumor with a low expression. Treatment with γ-interferon of carcinoma cells cultured in vitro induced a strong reexpression of H-2(q) antigens. Our results suggest that the immune response activated in vivo by HER-2/neu-positive tumors can lead to the emergence of escape variants characterized by a down-regulation of MHC class I products.

AB - Transgenic mice carrying the HER-2/neu proto-oncogene under tissue- specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells present the appropriate major histocompatibility complex (MHC) class I glycoproteins. The purpose of this work was to assess whether mammary carcinomas arising in Tg-MMTVneu mice correctly expressed MHC (H2(q)) class I gene products. We analyzed by flow cytometry 51 primary tumors from 19 transgenic mice. About one-half of the tumors showed a reduced expression of class I antigens. All tumors were highly positive for membrane neu. Some mice had multiple mammary carcinomas with widely different MHC expression levels, and most mice had at least one tumor with a low expression. Treatment with γ-interferon of carcinoma cells cultured in vitro induced a strong reexpression of H-2(q) antigens. Our results suggest that the immune response activated in vivo by HER-2/neu-positive tumors can lead to the emergence of escape variants characterized by a down-regulation of MHC class I products.

UR - http://www.scopus.com/inward/record.url?scp=0031870766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031870766&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19980911)77:6<937::AID-IJC24>3.0.CO;2-X

DO - 10.1002/(SICI)1097-0215(19980911)77:6<937::AID-IJC24>3.0.CO;2-X

M3 - Article

VL - 77

SP - 937

EP - 941

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -